Modified Method of Eversion Carotid Endarterectomy in Patients With Extensive Atherosclerotic Disease of Carotid Bifurcation

Sponsor
Pirogov Russian National Research Medical University (Other)
Overall Status
Completed
CT.gov ID
NCT04255316
Collaborator
(none)
126
1
2
29
4.3

Study Details

Study Description

Brief Summary

A prospective comparative randomized single-centre non-inferiority trial. The purpose of this study is to compares of modified method of eversion carotid endarterectomy with standard eversion carotid endarterectomy for 3,6 and 12 months days after operation in patients with extensive atherosclerotic disease of carotid bifurcation

Condition or Disease Intervention/Treatment Phase
  • Procedure: Modified method of eversion carotid endarterectomy
  • Procedure: Standard method of eversion carotid endarterectomy
N/A

Detailed Description

Introduction. Performing eversion endarterectomy some difficulties arise. Firstly, it requires a great deal of coherence between the work of the surgeon and the first assistant, as well as a great experience of the latter. Secondly, in some cases, there are difficulties in visualizing the distal margin of the intima: in the absence of a rigid skeleton, the soft unchanged artery walls after removal of the plaque subside, making it difficult to visualize possible fragments of the intima. Thirdly, the cost of the error is high: with a random de-version, repeated eversion turns out to be impossible. It should be noted that the use of an eversion technique becomes difficult to implement, and sometimes impossible, with extended stenosis, since a very high allocation of the ICA is required, which increases the invasiveness of the operation and the difficulty of access. With prolonged stenosis, the carotid endarterectomy remains the option of choice. The modification used eversion carotid endarterectomy combines the advantages of both methods, and also eliminates the limitations of the carotid endarterectomy and eversion carotid endarterectomy.

The aim of study. The purpose of this study is to compares of modified method of eversion carotid endarterectomy with standard eversion carotid endarterectomy for 3,6 and 12 months days after operation in patients with extensive atherosclerotic disease of carotid bifurcation

Study Design

Study Type:
Interventional
Actual Enrollment :
126 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Modified Method of Eversion Carotid Endarterectomy in Patients With Extensive Atherosclerotic Disease of Carotid Bifurcation
Actual Study Start Date :
Oct 1, 2017
Actual Primary Completion Date :
Feb 28, 2020
Actual Study Completion Date :
Mar 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Modified eversion

Patients with extensive atherosclerotic lesion of the carotid bifurcation (more 25mm in internal carotid artery) undergo a modified eversion carotid endarterectomy

Procedure: Modified method of eversion carotid endarterectomy
Mini approach for CCA bifurcation - Clamping ICA, ECA and CCA - ICA is cut off with a scalpel at the mouth itself - Dissection of the ICA and ECA in the distal direction to the distal border of the atherosclerotic plaque - Endarterectomy - Performing of a new bifurcation of the CCA with prolene 7/0

Active Comparator: Standard eversion

Patients with extensive atherosclerotic lesion of the carotid bifurcation (more 25mm in internal carotid artery) undergo a standard eversion carotid endarterectomy

Procedure: Standard method of eversion carotid endarterectomy
standard eversion technic

Outcome Measures

Primary Outcome Measures

  1. Assessment of total stroke rate [30 days]

    assessment of the total stroke rate in patients undergoing intervention after 30 days

  2. Assessment of mortality rate [30 days]

    assessment of the mortality rate in patients undergoing intervention after 30 days

Secondary Outcome Measures

  1. Assessment of stroke frequency [12 months]

    assessment of stroke frequency in patients undergoing intervention after 12 months

  2. Assessment of the incidence of internal carotid artery restenosis [3, 6, 12 months]

    Assessment of the incidence of internal carotid artery restenosis after 3, 6 and 12 months

Other Outcome Measures

  1. Evaluation of speed flow in carotid bifurcation by ultrasound duplex scan [24 hours, 30 days, 3, 6 and 12 months]

    Evaluation of speed flow, peak systolic velocity (cm/s) in common carotid artery, internal carotid artery and external carotid artery and their ratios using ultrasound duplex scan.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients with stenosis of ICA 70-99% (ultrasound - NASCET and CT angiography)

  • patients with a extensive lesion of the ICA (plaque < 2 cm) by ultrasound - NASCET and CT angiography

Exclusion Criteria:
  • patients with a extensive lesion of the ICA (plaque < 2 cm),

  • patients with a contralateral occlusion of the ICA

  • patients with stroke in ischemic type in the acute period.

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Federal Budget-Funded Institution National Medical Surgical Center named after N. I. Pirogov of the Ministry of health of the Russian Federation Moscow Russian Federation 117997

Sponsors and Collaborators

  • Pirogov Russian National Research Medical University

Investigators

  • Principal Investigator: Anatoly Virgansky, MD, The Federal Budget-Funded Institution National Medical Surgical Center named after N. I. Pirogov

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Pirogov Russian National Research Medical University
ClinicalTrials.gov Identifier:
NCT04255316
Other Study ID Numbers:
  • 23
First Posted:
Feb 5, 2020
Last Update Posted:
Jan 15, 2021
Last Verified:
Jan 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Pirogov Russian National Research Medical University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 15, 2021